How robust is ACTIVLIM for the follow-up of activity limitations in patients with neuromuscular diseases?

Cite this paper

@article{Batcho2016HowRI, title={How robust is ACTIVLIM for the follow-up of activity limitations in patients with neuromuscular diseases?}, author={Charles S{\`e}biyo Batcho and Peter Y K van den Bergh and Philip Van Damme and Anna J. Roy and Jean-Louis Thonnard and Massimo Penta}, journal={Neuromuscular disorders : NMD}, year={2016}, volume={26 3}, pages={211-20} }